Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

fibrosis
vcte
hepatic fibrosis
fatty liver
fibroscan
  • 0 views
  • 19 Feb, 2024
Prospective Cohort Study of Disease and Outcomes in Cirrhosis

A population based incidence cohort will enroll patients newly diagnosed with cirrhosis to investigate disease characteristics and outcomes, explore mechanisms predicting early death and hospital admission, and assess new monitoring tools in treatment and prevention of cirrhosis.

cirrhosis
imaging techniques
  • 0 views
  • 19 Feb, 2024
The European NAFLD Registry

The ultimate goals are to better understand the drivers of interpatient variation in disease pathophysiology and severity and to utilise this information to develop and validate biomarkers that, singly or in combination, enable detection and monitoring of disease progression and/or from NAFL through NASH to fibrosis and cirrhosis.

fibrosis
cirrhosis
hemoglobin a1c
type 2 diabetes mellitus
nonalcoholic fatty liver disease
  • 0 views
  • 19 Feb, 2024
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

The main aim of the study is to set up an observational cohort with NAFLD (Non-alcoholic fatty liver disease) at different stage of disease (from simple steatosis to cirrhosis and/or HCC-Hepatocellular carcinoma) and for comparative purpose a cohort of subjects with diabetes and/or obesity and/or other risk factors (i.e. psoriasis, …

cirrhosis
diabetes
liver disease
hepatitis c
non-alcoholic fatty liver
  • 0 views
  • 19 Feb, 2024
Characterization of Methylation Patterns in Hepatocellular Carcinoma

This study is being performed as part of the development process of the Liver EpiCheck test which includes the identification of different methylation profiles in HCC (hepatocellular carcinoma) patients compare to cancer free control in blood samples

cancer
cirrhosis
nash
ascites
hepatocellular carcinoma
  • 0 views
  • 19 Feb, 2024
Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2)

Evaluation of non-invasive prognostic parameters in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) for complications of portal hypertension. Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.

portosystemic shunt
hypertension
  • 0 views
  • 19 Feb, 2024
Efficacy of Narrow Band Spectrum Endoscopy for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver Cirrhosis

the study aims to evaluate the role of similar technology of Narrow Band Imaging VIST video intelligent staining technology in the diagnosis of Gastric Antral Vascular ectasia in cirrhotic patients

  • 0 views
  • 19 Feb, 2024
Malnutrition in Chronic Gastrointestinal Diseases Cross-sectional Study

The aim of the study is to compare data related to nutrition and physical condition of patients with liver cirrhosis, chronic pancreatitis and short bowel syndrome. Malnutrition and muscle wasting within the specific diseases will be characterized and possible correlations will be identified.

gastrointestinal disease
cirrhosis
pancreaticojejunostomy
mrcp
magnetic resonance cholangiopancreatography
  • 0 views
  • 19 Feb, 2024
Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference

This pilot study will evaluate conventional and investigational MR imaging and spectroscopic sequences and collect data to help plan more definitive future studies.

fibrosis
magnetic resonance elastography
steatohepatitis
nash
fatty liver
  • 0 views
  • 19 Feb, 2024